Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria :~* ICU patients on mechanical ventilation at the time of randomization~* Patients or legally authorized representative (LAR) giving written informed consent.~Exclusion criteria:~* Patients \<18 years of age;~* Documented Pseudomonas infection or colonization in the last 30 days;~* Immunocompromised patients~* Hypersensitivity to the study drug and/or to prior therapy with monoclonal antibodies;~* Patient who has taken other investigational drugs or prohibited therapy for this study within 1 month or 5 half-lives, whichever is longer;~* Patient or LAR who withdraws consent during the screening (starting from signed informed consent form);~* Acute liver injury related criteria at the time of study entry:~* Pregnant or breast-feeding women~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SAR279356 dose 1 (Type: EXPERIMENTAL): SAR279356 dose 1, single administration
- SAR279356 dose 2 (Type: EXPERIMENTAL): SAR279356 dose 2, single administration
- Placebo (Type: PLACEBO_COMPARATOR): Matching placebo, single administration

Based on this trial design, predict the completion outcome and termination type (if applicable).